tiprankstipranks
Advertisement
Advertisement

OPHLF Stock Latest News

ONO Pharmaceutical Q1: Record Sales, Margin Strain
Company AnnouncementsONO Pharmaceutical Q1: Record Sales, Margin Strain
21h ago
Ono Pharmaceutical Lifts Q1 Profits Despite Revenue Decline, Confirms FY2026 Outlook
PremiumCompany Announcements
Ono Pharmaceutical Lifts Q1 Profits Despite Revenue Decline, Confirms FY2026 Outlook
3d ago
Ono Pharma Halts Early Lymphoma Trial, Raising Fresh Questions for Investors
PremiumCompany Announcements
Ono Pharma Halts Early Lymphoma Trial, Raising Fresh Questions for Investors
4d ago
OPHLF
OPHLF Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
OPHLF Upcoming Earnings Report: What to Expect?
5d ago
Ono’s New GIST Study Puts Early‑Stage Oncology Back in Focus for OPHLF Investors
PremiumCompany Announcements
Ono’s New GIST Study Puts Early‑Stage Oncology Back in Focus for OPHLF Investors
13d ago
OPHLF
Ono Pharma’s ONO-1110 Pain Trial Reaches Completion, Setting Up a Key Readout
PremiumCompany AnnouncementsOno Pharma’s ONO-1110 Pain Trial Reaches Completion, Setting Up a Key Readout
18d ago
OPHLF
ONO-1110 Depression Trial Completion: What It Means for OPHLF Investors
Premium
Company Announcements
ONO-1110 Depression Trial Completion: What It Means for OPHLF Investors
25d ago
OPHLF
ONO’s ONO‑1110 Trial Completion Puts Social Anxiety Bet in Investor Focus
Premium
Company Announcements
ONO’s ONO‑1110 Trial Completion Puts Social Anxiety Bet in Investor Focus
25d ago
OPHLF
ONO’s Tirabrutinib Liver Study Completion: What It Means for OPHLF Investors
PremiumCompany Announcements
ONO’s Tirabrutinib Liver Study Completion: What It Means for OPHLF Investors
1M ago
OPHLF
Real-World Data on Nivolumab Plus Chemo in Japanese Gastric Cancer: What Investors Should Watch
PremiumCompany Announcements
Real-World Data on Nivolumab Plus Chemo in Japanese Gastric Cancer: What Investors Should Watch
2M ago
BMY
Ono’s ONO-4578 Breast Cancer Combo Clears Phase I Milestone, Setting Up the Next Investor Catalyst
PremiumCompany Announcements
Ono’s ONO-4578 Breast Cancer Combo Clears Phase I Milestone, Setting Up the Next Investor Catalyst
2M ago
OPHLF
ONO’s ONO-7018 Trial Termination: What It Means for OPHLF Investors
PremiumCompany Announcements
ONO’s ONO-7018 Trial Termination: What It Means for OPHLF Investors
2M ago
OPHLF
Ono’s Real-World Tirabrutinib Study in Taiwan Reaches Completion, Setting Up a New Catalyst for OPHLF
PremiumCompany AnnouncementsOno’s Real-World Tirabrutinib Study in Taiwan Reaches Completion, Setting Up a New Catalyst for OPHLF
2M ago
OPHLF
Ono’s Phase 3 Sapablursen Trial Targets Polycythemia Vera Upside for OPHLF Investors
Premium
Company Announcements
Ono’s Phase 3 Sapablursen Trial Targets Polycythemia Vera Upside for OPHLF Investors
3M ago
OPHLF
ONO Pharmaceutical Details FY2025 Results and FY2026 Outlook with Focus on Pipeline and Core Metrics
Premium
Company Announcements
ONO Pharmaceutical Details FY2025 Results and FY2026 Outlook with Focus on Pipeline and Core Metrics
3M ago
Ono Pharmaceutical Delivers Strong FY 2025 Profits but Guides for Lower Revenue in FY 2026
PremiumCompany Announcements
Ono Pharmaceutical Delivers Strong FY 2025 Profits but Guides for Lower Revenue in FY 2026
3M ago
Is OPHLF a Buy, Before Earnings?
PremiumPre-Earnings
Is OPHLF a Buy, Before Earnings?
3M ago
ONO Pharmaceutical Nears Key Readout in Lung Cancer Combo Trial With Tagrisso
PremiumCompany Announcements
ONO Pharmaceutical Nears Key Readout in Lung Cancer Combo Trial With Tagrisso
5M ago
OPHLF
ONO Pharmaceutical Posts Strong Profit Growth in Q3 FY2025 and Maintains Full-Year Outlook
PremiumCompany Announcements
ONO Pharmaceutical Posts Strong Profit Growth in Q3 FY2025 and Maintains Full-Year Outlook
6M ago
OPHLF Earnings this Week: How Will it Perform?
PremiumPre-EarningsOPHLF Earnings this Week: How Will it Perform?
6M ago
ONO Pharmaceutical Reports Strong Q2 Financial Performance with Revenue Growth
Premium
Company Announcements
ONO Pharmaceutical Reports Strong Q2 Financial Performance with Revenue Growth
9M ago
Ono Pharmaceutical’s Tirabrutinib Study: Key Insights for Investors
Premium
Company Announcements
Ono Pharmaceutical’s Tirabrutinib Study: Key Insights for Investors
9M ago
OPHLF

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >